SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-006801
Filing Date
2022-05-03
Accepted
2022-05-03 16:02:02
Documents
91
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bpmc-20220331x10q.htm   iXBRL 10-Q 1958714
2 EX-10.1 bpmc-20220331xex10d1.htm EX-10.1 834761
3 EX-10.2 bpmc-20220331xex10d2.htm EX-10.2 40253
4 EX-31.1 bpmc-20220331xex31d1.htm EX-31.1 11332
5 EX-31.2 bpmc-20220331xex31d2.htm EX-31.2 11403
6 EX-32.1 bpmc-20220331xex32d1.htm EX-32.1 10650
  Complete submission text file 0001558370-22-006801.txt   8948782

Data Files

Seq Description Document Type Size
7 EX-101.SCH bpmc-20220331.xsd EX-101.SCH 68236
8 EX-101.CAL bpmc-20220331_cal.xml EX-101.CAL 60258
9 EX-101.DEF bpmc-20220331_def.xml EX-101.DEF 243678
10 EX-101.LAB bpmc-20220331_lab.xml EX-101.LAB 494314
11 EX-101.PRE bpmc-20220331_pre.xml EX-101.PRE 426077
85 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20220331x10q_htm.xml XML 1334603
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37359 | Film No.: 22886723
SIC: 2834 Pharmaceutical Preparations